SLFN5 is expressed in estrogen receptor (ER)-positive breast cancer cells, while triple-negative breast cancer (TNBC) cells lack SLFN5 or exhibit very low levels [29,30]. This evidence concerns the gene SLFN5 and triple-negative breast carcinoma.